| Mysimba |
Human |
naltrexone;bupropion |
bupropion hydrochloride;naltrexone hydrochloride |
EMEA/H/C/003687 |
Orexigen Therapeutics Ireland Limited |
2015/03/26
|
Authorised |
| Dutrebis |
Human |
lamivudine;raltegravir potassium |
lamivudine;raltegravir potassium |
EMEA/H/C/003823 |
Merck Sharp Dohme Limited |
2015/03/26
|
Withdrawn |
| Quinsair |
Human |
levofloxacin |
levofloxacin |
EMEA/H/C/002789 |
Chiesi Farmaceutici S.p.A |
2015/03/25
|
Authorised |
| Kengrexal |
Human |
cangrelor |
cangrelor |
EMEA/H/C/003773 |
Chiesi Farmaceutici S.p.A. |
2015/03/23
|
Authorised |
| Saxenda |
Human |
liraglutide |
liraglutide |
EMEA/H/C/003780 |
Novo Nordisk A/S |
2015/03/23
|
Authorised |
| Sivextro |
Human |
tedizolid phosphate |
|
EMEA/H/C/002846 |
Merck Sharp & Dohme B.V. |
2015/03/23
|
Authorised |
| Ikervis |
Human |
ciclosporin |
ciclosporin |
EMEA/H/C/002066 |
Santen Oy |
2015/03/19
|
Authorised |
| Tenkasi (previously Orbactiv) |
Human |
oritavancin |
oritavancin (diphosphate) |
EMEA/H/C/003785 |
Menarini International Operations Luxembourg S.A. |
2015/03/19
|
Authorised |
| Raplixa |
Human |
human fibrinogen;human thrombin |
human fibrinogen;human thrombin |
EMEA/H/C/002807 |
Mallinckrodt Pharmaceuticals Ireland Limited |
2015/03/19
|
Withdrawn |
| Vantobra |
Human |
tobramycin |
tobramycin |
EMEA/H/C/002633 |
Pari Pharma GmbH |
2015/03/18
|
Withdrawn |
| Coliprotec F4 |
Veterinary |
Escherichia coli, type 08, strain K87 (live) |
live non-pathogenic Escherichia coli O8:K87 |
EMEA/V/C/003797 |
Prevtec Microbia GmbH |
2015/03/16
|
Withdrawn |
| Tasermity |
Human |
sevelamer hydrochloride |
sevelamer hydrochloride |
EMEA/H/C/003968 |
Genzyme Europe BV |
2015/02/25
|
Lapsed |
| Xadago |
Human |
safinamide |
safinamide methanesulfonate |
EMEA/H/C/002396 |
Zambon SpA |
2015/02/23
|
Authorised |
| Xydalba |
Human |
dalbavancin |
dalbavancin hydrochloride |
EMEA/H/C/002840 |
AbbVie Deutschland GmbH & Co. KG |
2015/02/19
|
Authorised |
| Clopidogrel ratiopharm |
Human |
clopidogrel |
clopidogrel (as hydrogen sulfate) |
EMEA/H/C/004006 |
Teva B.V. |
2015/02/18
|
Authorised |
| Holoclar |
Human |
ex vivo expanded autologous human corneal epithelial cells containing stem cells |
ex vivo expanded autologous human corneal epithelial cells containing stem cells |
EMEA/H/C/002450 |
Holostem s.r.l. |
2015/02/17
|
Authorised |
| Cerdelga |
Human |
eliglustat |
Eliglustat (tartrate) |
EMEA/H/C/003724 |
Sanofi B.V. |
2015/01/19
|
Authorised |
| Zontivity |
Human |
vorapaxar |
vorapaxar sulfate |
EMEA/H/C/002814 |
Merck Sharp Dohme Limited |
2015/01/19
|
Withdrawn |
| Otezla |
Human |
apremilast |
apremilast |
EMEA/H/C/003746 |
Amgen Europe B.V. |
2015/01/15
|
Authorised |
| Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) |
Human |
sevelamer carbonate |
sevelamer carbonate |
EMEA/H/C/003971 |
Sanofi Winthrop Industrie |
2015/01/15
|
Authorised |